Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis-Reference-Cited by-同舟云学术

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Published:2014-01 Issue:1 Volume:146 Page:85-95
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sandborn William J.,Feagan Brian G.,Marano Colleen,Zhang Hongyan,Strauss Richard,Johanns Jewel,Adedokun Omoniyi J.,Guzzo Cynthia,Colombel Jean-Frederic,Reinisch Walter,Gibson Peter R.,Collins Judith,Järnerot Gunnar,Hibi Toshifumi,Rutgeerts Paul

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Ulcerative colitis;Ordás;Lancet,2012

2. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

3. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial;Reinisch;Gut,2011

4. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2012

5. Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor alpha;Shealy;MAbs,2010

Cited by 756 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the immune landscape of disulfidptosis in ulcerative colitis and the role of modified gegen qinlian decoction in mediating disulfidptosis to alleviate colitis in mice;Journal of Ethnopharmacology;2024-11

2. Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12

3. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems;Pharmaceutics;2024-09-07

4. Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection;Cureus;2024-09-03

5. A metabolic switch orchestrated by IL-18 and the cyclic dinucleotide cGAMP programs intestinal tolerance;Immunity;2024-09